- Home
- HBIO vs PIII Comparison
HBIO vs PIII Comparison
Compare HBIO & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- PIII
- Stock Information
- Founded
- HBIO 1901
- PIII 2015
- Country
- HBIO United States
- PIII United States
- Employees
- HBIO N/A
- PIII N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- PIII Medical/Nursing Services
- Sector
- HBIO Industrials
- PIII Health Care
- Exchange
- HBIO Nasdaq
- PIII Nasdaq
- Market Cap
- HBIO 24.6M
- PIII 20.8M
- IPO Year
- HBIO 2000
- PIII N/A
- Fundamental
- Price
- HBIO $0.49
- PIII $8.27
- Analyst Decision
- HBIO Buy
- PIII Strong Buy
- Analyst Count
- HBIO 2
- PIII 3
- Target Price
- HBIO $3.00
- PIII $17.50
- AVG Volume (30 Days)
- HBIO 505.4K
- PIII 7.1K
- Earning Date
- HBIO 08-11-2025
- PIII 08-14-2025
- Dividend Yield
- HBIO N/A
- PIII N/A
- EPS Growth
- HBIO N/A
- PIII N/A
- EPS
- HBIO N/A
- PIII N/A
- Revenue
- HBIO $88,750,000.00
- PIII $1,461,823,000.00
- Revenue This Year
- HBIO N/A
- PIII N/A
- Revenue Next Year
- HBIO $7.13
- PIII $9.46
- P/E Ratio
- HBIO N/A
- PIII N/A
- Revenue Growth
- HBIO N/A
- PIII 4.20
- 52 Week Low
- HBIO $0.28
- PIII $5.80
- 52 Week High
- HBIO $3.04
- PIII $29.19
- Technical
- Relative Strength Index (RSI)
- HBIO 48.68
- PIII 66.79
- Support Level
- HBIO $0.49
- PIII $7.19
- Resistance Level
- HBIO $0.54
- PIII $8.78
- Average True Range (ATR)
- HBIO 0.04
- PIII 0.49
- MACD
- HBIO -0.00
- PIII 0.13
- Stochastic Oscillator
- HBIO 19.20
- PIII 77.80
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.